<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sleep Adv</journal-id><journal-id journal-id-type="iso-abbrev">Sleep Adv</journal-id><journal-id journal-id-type="pmc-domain-id">4422</journal-id><journal-id journal-id-type="pmc-domain">sleepadv</journal-id><journal-id journal-id-type="publisher-id">sleepadvances</journal-id><journal-title-group><journal-title>Sleep Advances: A Journal of the Sleep Research Society</journal-title></journal-title-group><issn pub-type="epub">2632-5012</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11450625</article-id><article-id pub-id-type="pmcid-ver">PMC11450625.1</article-id><article-id pub-id-type="pmcaid">11450625</article-id><article-id pub-id-type="pmcaiid">11450625</article-id><article-id pub-id-type="pmid">39372542</article-id><article-id pub-id-type="doi">10.1093/sleepadvances/zpae054</article-id><article-id pub-id-type="publisher-id">zpae054</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00370</subject><subject>AcademicSubjects/MED00310</subject><subject>AcademicSubjects/MED00385</subject><subject>AcademicSubjects/SCI01870</subject></subj-group></article-categories><title-group><article-title>Clinical and financial significance of insomnia within a large payor-provider health system</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Karlin</surname><given-names initials="BE">Bradley E</given-names></name><aff>
<institution>Enterprise Behavioral Health, Highmark Health</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University</institution>, <addr-line>Baltimore, MD</addr-line>, <country country="US">USA</country></aff><xref rid="c1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Anderson</surname><given-names initials="RJ">Ryan J</given-names></name><aff>
<institution>Enterprise Behavioral Health, Highmark Health</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rung</surname><given-names initials="JM">Jillian M</given-names></name><aff>
<institution>Enterprise Data &amp; Analytics, Highmark Health</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5084-3127</contrib-id><name name-style="western"><surname>Drury-Gworek</surname><given-names initials="C">Charlotte</given-names></name><aff>
<institution>Enterprise Data &amp; Analytics, Highmark Health</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barrett</surname><given-names initials="TS">Tyson S</given-names></name><aff>
<institution>Enterprise Data &amp; Analytics, Highmark Health</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country country="US">USA</country></aff></contrib></contrib-group><author-notes><corresp id="c1">Corresponding author. Bradley E. Karlin, Solutions for Mental Health Change, LLC,&#160;Pittsburgh, PA, USA. Email: <email>bradkarlin@gmail.com</email>.</corresp></author-notes><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-07-27"><day>27</day><month>7</month><year>2024</year></pub-date><volume>5</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">453910</issue-id><elocation-id>zpae054</elocation-id><history><date date-type="received"><day>18</day><month>5</month><year>2023</year></date><date date-type="rev-recd"><day>15</day><month>12</month><year>2023</year></date><date date-type="corrected-typeset"><day>04</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>04</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-09 00:25:37.463"><day>09</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024. Published by Oxford University Press on behalf of Sleep Research Society.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="zpae054.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zpae054.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="companion" xml:lang="en" xlink:title="research-article" journal-id="Sleep Adv" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC11450627"><article-title>Impact of real-world implementation of evidence-based insomnia treatment within a large payor-provider health system: initial provider and patient-level outcomes</article-title><volume>5</volume><issue>1</issue><date><day>27</day><month>7</month><year>2024</year></date><elocation-id>zpae053</elocation-id><source>Sleep Advances: A Journal of the Sleep Research Society</source><pub-id pub-id-type="doi">10.1093/sleepadvances/zpae053</pub-id><pub-id pub-id-type="pmcid">PMC11450627</pub-id><pub-id pub-id-type="pmid">39372543</pub-id></related-article><abstract><title>Abstract</title><sec id="s1"><title>Study Objectives</title><p>Insomnia has profound negative effects on behavioral health, physical health, and functional domains. Leveraging claims data from one of the nation&#8217;s largest payor-provider systems, the current study examined the real-world prevalence of insomnia, comorbidity of insomnia with behavioral health and other sleep disorders, and the impact of insomnia on total health care costs.</p></sec><sec id="s2"><title>Methods</title><p>Prevalence and costs associated with insomnia were assessed by examining claims data on approximately 3 million insured members during the year 2022. Using propensity score matching, total health care expenditures were calculated and compared for members with insomnia relative to matched cohorts without insomnia. Generalized linear modeling tested for differences between the cohorts.</p></sec><sec id="s3"><title>Results</title><p>Nine percent of members were identified as having insomnia; 64% of those also had depression, anxiety, and/or substance use disorder. Median total health care costs among individuals with insomnia were 4&#8211;6 times greater than among those without insomnia. A disproportionate amount (21.1%) of total claims spend came from members with insomnia.</p></sec><sec id="s4"><title>Conclusions</title><p>Findings demonstrate a high degree of clinical need and behavioral health comorbidity associated with insomnia within a large insured cohort. Beyond the clinical significance, the current results demonstrate substantial financial need and opportunity for adequately treating insomnia. This is especially the case for the high proportion of members with insomnia and cooccurring depression, anxiety, and/or substance use disorders. Overall, the findings point to the important role payors and providers may have in promoting greater attention to sleep and insomnia.</p></sec></abstract><kwd-group><kwd>insomnia</kwd><kwd>cognitive behavioral therapy</kwd><kwd>health care utilization and costs</kwd><kwd>psychiatric disorders</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Richard King Mellon Foundation</institution><institution-id institution-id-type="DOI">10.13039/100000915</institution-id></institution-wrap></funding-source><award-id>#10714</award-id></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Highmark Health</institution></institution-wrap></funding-source></award-group></funding-group><counts><page-count count="7"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text position="float" orientation="portrait"><caption><title>Statement of Significance</title></caption><p>Insomnia has substantial negative effects on physical and behavioral health and overall functioning. The current article examined the prevalence and health care costs associated with insomnia in a sample of approximately 3 million insured members. Findings demonstrate high rates of insomnia among members, with the highest rates among older adults. Close to two-thirds of those with insomnia also had a depression, anxiety, and/or substance use disorder diagnosis. Median total health care costs among those with insomnia were 4-6 times greater than among those without insomnia. The findings point to the important role payors and providers may have in promoting greater attention to sleep and insomnia.</p></boxed-text><p>Insomnia is among the most pervasive, impactful, and treatable public health concerns in the United States. Approximately 10%&#8211;15% of adults experience an insomnia disorder and another 20% have subclinical insomnia symptoms [<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0002" ref-type="bibr">2</xref>]. The rate of sleep disturbance in older adults has been reported to be as high as 50% [<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0004" ref-type="bibr">4</xref>]. At the same time, untreated insomnia has been shown to have profound negative consequences in numerous domains [<xref rid="CIT0005" ref-type="bibr">5</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>]. These include decreased quality of life [<xref rid="CIT0007" ref-type="bibr">7&#8211;9</xref>], poor physical functioning [<xref rid="CIT0010" ref-type="bibr">10</xref>], decreased ability to perform activities of daily living [<xref rid="CIT0007" ref-type="bibr">7</xref>], increased risk of falls [<xref rid="CIT0011" ref-type="bibr">11</xref>, <xref rid="CIT0012" ref-type="bibr">12</xref>], increased healthcare utilization [<xref rid="CIT0013" ref-type="bibr">13</xref>], increased mortality and [<xref rid="CIT0014" ref-type="bibr">14</xref>], increased risk of depression and other behavioral health conditions [<xref rid="CIT0007" ref-type="bibr">7</xref>, <xref rid="CIT0015" ref-type="bibr">15</xref>, <xref rid="CIT0016" ref-type="bibr">16</xref>], In addition, a spate of research has demonstrated insomnia to be associated with increased risk of cardiovascular disease [<xref rid="CIT0017" ref-type="bibr">17</xref>], cognitive decline [<xref rid="CIT0018" ref-type="bibr">18&#8211;24</xref>], and Alzheimer&#8217;s disease [<xref rid="CIT0025" ref-type="bibr">25&#8211;27</xref>]. In their review of the effects of insomnia, Sivertsen et al. [<xref rid="CIT0028" ref-type="bibr">28</xref>] declared, &#8220;We conclude that insomnia predicts cumulative incidence of several physical and mental conditions.&#8221;</p><p>In addition to the clinical and functional impact of insomnia, available data in the literature point to the considerable costs of untreated insomnia and suggest significant financial savings associated with insomnia treatment, in terms of both health care costs (direct effects) and productivity, worker absenteeism, and quality of life (indirect effects) [<xref rid="CIT0029" ref-type="bibr">29&#8211;34</xref>]. The costs associated with insomnia are particularly significant in older adults, largely due to increased fall and fracture risk associated with the use of hypnotics in this age group [<xref rid="CIT0035" ref-type="bibr">35</xref>]. Moreover, left untreated, insomnia is often highly enduring in nature and further compounds negative financial impact [<xref rid="CIT0001" ref-type="bibr">1</xref>]. While still developing in its empirical maturity, an accumulating body of research examining the impact of insomnia treatment on health care costs indicates that treatment of insomnia is associated with lower health care expenditures [<xref rid="CIT0031" ref-type="bibr">31</xref>, <xref rid="CIT0036" ref-type="bibr">36</xref>, <xref rid="CIT0037" ref-type="bibr">37</xref>]. Consequently, the foregoing findings suggest that increased attention to and treatment of insomnia may confer numerous benefits central to the quintuple aim and reduced impact of care.</p><p>Unfortunately, insomnia is widely under-reported, unrecognized, and under-detected in primary care and other clinical settings due to numerous barriers at provider, systems, and patient levels [<xref rid="CIT0038" ref-type="bibr">38</xref>, <xref rid="CIT0039" ref-type="bibr">39</xref>]. When insomnia is detected, it is frequently undertreated [<xref rid="CIT0040" ref-type="bibr">40</xref>]. The mainstay treatment for insomnia consists of sleep medications, which have limited efficacy and can confer adverse reactions, especially when used for more than brief periods [<xref rid="CIT0041" ref-type="bibr">41</xref>]. Although highly undetected and undertreated, insomnia is highly treatable. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a highly efficacious, brief treatment recommended at the highest level and as first-line treatment for insomnia in clinical practice guidelines [<xref rid="CIT0042" ref-type="bibr">42</xref>, <xref rid="CIT0043" ref-type="bibr">43</xref>]. Beyond its effectiveness in improving insomnia, CBT-I has also been shown to improve symptoms of depression and other behavioral health conditions that are often comorbid with insomnia [<xref rid="CIT0044" ref-type="bibr">44</xref>, <xref rid="CIT0045" ref-type="bibr">45</xref>]. Yet, this gold-standard treatment remains widely unavailable in real-world treatment settings [<xref rid="CIT0046" ref-type="bibr">46</xref>].</p><p>The current study was conducted to examine the prevalence of insomnia, as well as cooccurring behavioral health conditions, and the costs associated with members with insomnia for informing decisions and plans for structured implementation of CBT-I within one of the nation&#8217;s largest payor-provider health systems [<xref rid="CIT0047" ref-type="bibr">47</xref>]. Leveraging a robust claims data system encompassing nearly 3 million members nationally, the current evaluation examined (1) the current prevalence of insomnia and cooccurring behavioral health conditions and (2) the health care costs associated with individuals with insomnia and cooccurring behavioral health conditions among insured members across multiple insurance product lines (Commercial, Affordable Care Act, Medicare Advantage, and Medicaid). Specific questions the evaluation seeks to address include: what is the prevalence of insomnia and cooccurring behavioral health conditions in a large real-world community sample of insured members? What are the total health care costs associated with members with insomnia? What are the incremental and relative health care costs associated with having different types of cooccurring behavioral health conditions with insomnia? It was anticipated that, relative to individuals without insomnia, the total health care expenditures of members with insomnia would be significantly higher&#8212;and even more so among those with insomnia and cooccurring behavioral health needs (i.e. depression, anxiety, and/or substance use disorder).</p><sec sec-type="materials" id="s5"><title>Method</title><sec id="s6"><title>Data extraction and identification</title><p>Insomnia prevalence and expenditure analyses were conducted on all approved claims from January 01, 2022 through December 31, 2022, using all adult members between 18 and 100 years old with at least 6 months of continuous enrollment during 2022 (<italic toggle="yes">N</italic>&#8197;=&#8197;2.9 million members). Members were identified as having insomnia if any of the following criteria were met during the 2022 calendar year: a claim with an insomnia diagnosis in any diagnosis code field; a claim with an Episode Treatment Group (ETG) code indicating insomnia; or a claim for insomnia-related medication, consistent with past approaches [<xref rid="CIT0048" ref-type="bibr">48</xref>, <xref rid="CIT0049" ref-type="bibr">49</xref>]. We also reviewed available electronic health record (EHR) data for encounters containing a diagnosis of insomnia and cross-referenced the corresponding patients within the claims database to be fully inclusive in the identification of members with insomnia. Insomnia-related medications included benzodiazepines FDA-approved for the treatment of insomnia, nonbenzodiazepine sedative-hypnotics (i.e. Z-drugs), orexin receptor antagonists, melatonin receptor agonists, select antidepressants prescribed at low doses for sleep (e.g. doxepin, trazodone), and select first-generation antihistamines commonly used to treat insomnia (e.g. doxylamine succinate). See <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref> in the Appendix for the full list of medications.</p></sec><sec id="s7"><title>Prevalence analyses</title><p>Prevalence estimates were calculated by taking the count of members identified with insomnia and dividing it by the total count of all included members. Subgroup analyses were then conducted to stratify by sex, age, and insurance type. In addition to the examination of the prevalence of insomnia, we examined the prevalence of one or more core behavioral health conditions (depression, anxiety, and/or substance use disorder) using ETG codes and ICD-10 codes from claims, as well as non-insomnia sleep conditions, consistent with the International Classification of Sleep Disorders&#8212;Third Edition (ICSD-3-TR). Non-insomnia sleep disorders included (1) sleep-related breathing disorders (e.g. obstructive sleep apnea, central sleep apnea syndromes), (2) central disorders of hypersomnolence (e.g. narcolepsy, idiopathic hypersomnia), (3) circadian rhythm sleep&#8211;wake disorders (e.g. delayed sleep&#8211;wake phase disorder), (4) parasomnias (REM-related parasomnias; e.g. nightmare disorder and NREM-related parasomnias; e.g. sleepwalking), and (5) sleep-related movement disorders (e.g. restless leg syndrome, sleep-related bruxism).</p></sec><sec id="s8"><title>Expenditure analyses</title><p>Expenditure analyses examined the total health care costs of members with insomnia relative to a matched group of members without insomnia. First, the proportion of total health care expenditures in 2022 attributable to members with insomnia was calculated. Specifically, we determined the average TCC by calculating the per member per month (PMPM) spend for members with insomnia. PMPM spending was calculated using the sum of the allowed amounts across all claims for each member divided by the number of months that member was enrolled during 2022. To account for other factors that may impact costs, we compared PMPM spending between members with insomnia to a matched cohort of members without insomnia. Next, to examine the financial impact of having insomnia while having cooccurring behavioral health conditions, we compared the costs of those with insomnia and comorbid depression, anxiety, and/or substance use disorder to the costs of matched cohorts without insomnia but with the same comorbid behavioral health condition(s). In total, there were five matched cohorts created for cost comparison&#8212;a broad cohort of those with and without insomnia (regardless of comorbidities), and four on the basis of the comorbidity groupings. The five cohort comparisons are listed below:</p><list list-type="order"><list-item><p>Insomnia versus no insomnia.</p></list-item><list-item><p>Insomnia&#8197;+&#8197;depression versus no insomnia&#8197;+&#8197;depression.</p></list-item><list-item><p>Insomnia&#8197;+&#8197;anxiety versus no insomnia&#8197;+&#8197;anxiety.</p></list-item><list-item><p>Insomnia&#8197;+&#8197;substance use disorder versus no insomnia&#8197;+&#8197;substance use disorder.</p></list-item><list-item><p>Insomnia&#8197;+&#8197;1 or more of these comorbidities versus no insomnia&#8197;+&#8197;1 or more of these comorbidities.</p></list-item></list><p>The matched no-insomnia groups for the five cohort-based comparisons were created using propensity score matching for the average treatment effect on the treated (i.e. the estimated impact of insomnia based on those in the sample who were identified as having insomnia). Matching was performed with replacement, such that a comparison member without insomnia could serve as the matched counterpart for more than one member with insomnia. Propensity scores were estimated using a logistic model; the predictors in the model&#8212;the characteristics the groups were matched on&#8212;were demographic characteristics and comorbidities (e.g. age, sex, depression, anxiety, all comorbidities in the Charlson Comorbidity Index) [<xref rid="CIT0050" ref-type="bibr">50</xref>]. Exact matching was used for sex. The adequacy of the matching (i.e. the balance of the groups) was assessed using standardized mean differences, variance ratios, Kolmogorov-Smirnov statistics (&#8220;empirical cumulative density functions&#8221;), and screening for outliers. With the matched samples, PMPM spending was compared using descriptive statistics&#8212;both mean and median to provide representative estimates of the typical individual PMPM&#8212;and generalized linear regression modeling. The regression models used a gamma distribution and a natural logarithm link. Prevalence and expenditure analyses were conducted using RStudio Workbench (v 1.4.1717-3) running <italic toggle="yes">R</italic> (v. 4.0.0).</p></sec></sec><sec id="s9"><title>Results</title><p>Rates of insomnia and core behavioral health comorbidities across all members and by specific insured segments are reported in <xref rid="T1" ref-type="table">Table 1</xref>. As <xref rid="T1" ref-type="table">Table 1</xref> reveals, the overall frequency of insomnia across adult members in the year 2022 with 6 or more months of continuous enrollment was 8.9%. Of the members with insomnia, a majority (64%) also had a depression, anxiety, and/or substance use disorder diagnosis. Among members with depression, anxiety, and/or substance use disorders, 20.1% had an insomnia diagnosis. Prevalence of insomnia varied by member characteristics, with higher rates observed for females, older individuals, and Medicare Advantage members. Of those with insomnia, 28.0% also had a sleep-related breathing disorder, 7.9% had a sleep-related movement disorder, 6.6% had hypersomnolence, 1.7% had a diagnosis of circadian rhythm sleep disorders, and 1.5% had parasomnia. Across the full membership, a disproportionate amount (21.1%) of all expenditures were attributable to members with insomnia.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1.</label><caption><p>Percentages of Insured Members (With 6 Months of Continuous Enrollment) With Insomnia, Combinations of Insomnia and Behavioral Health Comorbidities, and Corresponding Demographic Characteristics of the Aforementioned Groupings</p></caption><table frame="hsides" rules="groups" width="100%" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="8" rowspan="1">Population</th></tr><tr><th align="left" rowspan="1" colspan="1">Diagnoses</th><th align="left" rowspan="1" colspan="1">Overall</th><th align="left" rowspan="1" colspan="1">Male</th><th align="left" rowspan="1" colspan="1">Female</th><th align="left" rowspan="1" colspan="1">Age&#8197;&lt;&#8197;65</th><th align="left" rowspan="1" colspan="1">Age &#8805; 65</th><th align="left" rowspan="1" colspan="1">Medicare advantage</th><th align="left" rowspan="1" colspan="1">Private insurance</th><th align="left" rowspan="1" colspan="1">Other insurance</th></tr></thead><tbody><tr><td align="left" colspan="9" rowspan="1">
<italic toggle="yes">Of all members (N&#8197;=&#8197;2&#160;824&#160;550)</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia (<italic toggle="yes">n</italic>&#8197;=&#8197;252&#160;233)</td><td align="left" rowspan="1" colspan="1">8.93%</td><td align="left" rowspan="1" colspan="1">7.40%</td><td align="left" rowspan="1" colspan="1">10.22%</td><td align="left" rowspan="1" colspan="1">7.86%</td><td align="left" rowspan="1" colspan="1">13.09%</td><td align="left" rowspan="1" colspan="1">17.28%</td><td align="left" rowspan="1" colspan="1">7.84%</td><td align="left" rowspan="1" colspan="1">9.02%</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and depression (<italic toggle="yes">n</italic>&#8197;=&#8197;92&#160;793)</td><td align="left" rowspan="1" colspan="1">3.29%</td><td align="left" rowspan="1" colspan="1">2.15%</td><td align="left" rowspan="1" colspan="1">4.24%</td><td align="left" rowspan="1" colspan="1">2.91%</td><td align="left" rowspan="1" colspan="1">4.73%</td><td align="left" rowspan="1" colspan="1">7.20%</td><td align="left" rowspan="1" colspan="1">2.84%</td><td align="left" rowspan="1" colspan="1">3.09%</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and anxiety (<italic toggle="yes">n</italic>&#8197;=&#8197;129&#160;777)</td><td align="left" rowspan="1" colspan="1">4.59%</td><td align="left" rowspan="1" colspan="1">3.16%</td><td align="left" rowspan="1" colspan="1">5.81%</td><td align="left" rowspan="1" colspan="1">4.28%</td><td align="left" rowspan="1" colspan="1">5.82%</td><td align="left" rowspan="1" colspan="1">8.49%</td><td align="left" rowspan="1" colspan="1">4.20%</td><td align="left" rowspan="1" colspan="1">4.24%</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and SUD (<italic toggle="yes">n</italic>&#8197;=&#8197;25&#160;638)</td><td align="left" rowspan="1" colspan="1">0.91%</td><td align="left" rowspan="1" colspan="1">0.96%</td><td align="left" rowspan="1" colspan="1">0.87%</td><td align="left" rowspan="1" colspan="1">0.92%</td><td align="left" rowspan="1" colspan="1">0.84%</td><td align="left" rowspan="1" colspan="1">1.51%</td><td align="left" rowspan="1" colspan="1">0.89%</td><td align="left" rowspan="1" colspan="1">0.71%</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and 1&#8197;+&#8197;COM (<italic toggle="yes">n</italic>&#8197;=&#8197;161&#160;414)</td><td align="left" rowspan="1" colspan="1">5.71%</td><td align="left" rowspan="1" colspan="1">4.17%</td><td align="left" rowspan="1" colspan="1">7.02%</td><td align="left" rowspan="1" colspan="1">5.21%</td><td align="left" rowspan="1" colspan="1">7.69%</td><td align="left" rowspan="1" colspan="1">11.19%</td><td align="left" rowspan="1" colspan="1">5.13%</td><td align="left" rowspan="1" colspan="1">5.32%</td></tr><tr><td align="left" rowspan="1" colspan="1">No insomnia and 1&#8197;+&#8197;COM (<italic toggle="yes">n</italic>&#8197;=&#8197;641&#160;327)</td><td align="left" rowspan="1" colspan="1">22.71%</td><td align="left" rowspan="1" colspan="1">17.29%</td><td align="left" rowspan="1" colspan="1">27.26%</td><td align="left" rowspan="1" colspan="1">23.29%</td><td align="left" rowspan="1" colspan="1">20.43%</td><td align="left" rowspan="1" colspan="1">23.08%</td><td align="left" rowspan="1" colspan="1">23.22%</td><td align="left" rowspan="1" colspan="1">20.76%</td></tr><tr><td align="left" colspan="9" rowspan="1">
<italic toggle="yes">Of members with insomnia (n&#8197;=&#8197;252&#160;233)</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">1&#8197;+&#8197;COM (<italic toggle="yes">n</italic>&#8197;=&#8197;161&#160;414)</td><td align="left" rowspan="1" colspan="1">63.99%</td><td align="left" rowspan="1" colspan="1">56.29%</td><td align="left" rowspan="1" colspan="1">68.70%</td><td align="left" rowspan="1" colspan="1">66.24%</td><td align="left" rowspan="1" colspan="1">58.74%</td><td align="left" rowspan="1" colspan="1">64.76%</td><td align="left" rowspan="1" colspan="1">65.44%</td><td align="left" rowspan="1" colspan="1">58.99%</td></tr><tr><td align="left" colspan="9" rowspan="1">
<italic toggle="yes">Of members with 1+ COM (n&#8197;=&#8197;802&#160;741)</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia (<italic toggle="yes">n</italic>&#8197;=&#8197;161&#160;414)</td><td align="left" rowspan="1" colspan="1">20.11%</td><td align="left" rowspan="1" colspan="1">19.42%</td><td align="left" rowspan="1" colspan="1">20.47%</td><td align="left" rowspan="1" colspan="1">18.28%</td><td align="left" rowspan="1" colspan="1">27.35%</td><td align="left" rowspan="1" colspan="1">32.65%</td><td align="left" rowspan="1" colspan="1">18.10%</td><td align="left" rowspan="1" colspan="1">20.39%</td></tr></tbody></table><table-wrap-foot><fn id="T1Fn1"><p>SUD, substance use disorder; COM, comorbidity. Comorbidities included depression, anxiety, and SUD.</p></fn></table-wrap-foot></table-wrap><p>The propensity score matching for the five cohorts was adequately balanced across all demographic characteristics and comorbidities. That is, all balance metrics were within generally acceptable limits. For instance, all absolute standardized mean differences were less than 0.2, variance ratios were all less than 2.0, and Kolmogorov-Smirnov statistics (&#8220;empirical cumulative density function maximum&#8221;) were all below 0.11. The sample sizes of the matched cohorts are reported in <xref rid="T2" ref-type="table">Table 2</xref>. The results of the expenditure analyses comparing those with insomnia to matched groups without insomnia reveal that individuals with insomnia have 2 to 3 times higher mean total care costs and 4 to 6 times higher median total care costs than their non-insomnia counterparts, with expenditures generally even greater in the presence of behavioral health comorbidity (<xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2.</label><caption><p>Mean, Median, Mean Ratio, and Median Ratio Showing Per-member Per-month Cost Differences in Each Matched Cohort</p></caption><table frame="hsides" rules="groups" width="100%" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Comparison</th><th align="left" rowspan="1" colspan="1">Mean</th><th align="left" rowspan="1" colspan="1">Median</th><th align="left" rowspan="1" colspan="1">Mean ratio</th><th align="left" rowspan="1" colspan="1">Median ratio</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Insomnia vs. no insomnia</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.10</td><td align="left" rowspan="1" colspan="1">4.45</td></tr><tr><td align="left" rowspan="1" colspan="1">No insomnia (<italic toggle="yes">n</italic>&#8197;=&#8197;159&#160;850)</td><td align="left" rowspan="1" colspan="1">$867</td><td align="left" rowspan="1" colspan="1">$116</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia (<italic toggle="yes">n</italic>&#8197;=&#8197;252&#160;233)</td><td align="left" rowspan="1" colspan="1">$1823</td><td align="left" rowspan="1" colspan="1">$516</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="3" rowspan="1">Insomnia and depression vs. no insomnia and depression</td><td align="left" rowspan="1" colspan="1">2.97</td><td align="left" rowspan="1" colspan="1">5.72</td></tr><tr><td align="left" rowspan="1" colspan="1">No insomnia and depression (<italic toggle="yes">n</italic>&#8197;=&#8197;40&#160;421)</td><td align="left" rowspan="1" colspan="1">$725</td><td align="left" rowspan="1" colspan="1">$127</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and depression (<italic toggle="yes">n</italic>&#8197;=&#8197;92&#160;793)</td><td align="left" rowspan="1" colspan="1">$2150</td><td align="left" rowspan="1" colspan="1">$727</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="3" rowspan="1">Insomnia and anxiety vs. no insomnia and anxiety</td><td align="left" rowspan="1" colspan="1">2.57</td><td align="left" rowspan="1" colspan="1">5.09</td></tr><tr><td align="left" rowspan="1" colspan="1">No insomnia and anxiety (<italic toggle="yes">n</italic>&#8197;=&#8197;61&#160;768)</td><td align="left" rowspan="1" colspan="1">$821</td><td align="left" rowspan="1" colspan="1">$127</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and anxiety (<italic toggle="yes">n</italic>&#8197;=&#8197;129&#160;777)</td><td align="left" rowspan="1" colspan="1">$2107</td><td align="left" rowspan="1" colspan="1">$646</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="3" rowspan="1">Insomnia and SUD vs. No insomnia and SUD</td><td align="left" rowspan="1" colspan="1">2.35</td><td align="left" rowspan="1" colspan="1">4.01</td></tr><tr><td align="left" rowspan="1" colspan="1">No insomnia and SUD (<italic toggle="yes">n</italic>&#8197;=&#8197;13&#160;421)</td><td align="left" rowspan="1" colspan="1">$1430</td><td align="left" rowspan="1" colspan="1">$314</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and SUD (<italic toggle="yes">n</italic>&#8197;=&#8197;25&#160;638)</td><td align="left" rowspan="1" colspan="1">$3355</td><td align="left" rowspan="1" colspan="1">$1260</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="3" rowspan="1">Insomnia and at least one comorbidity vs. no insomnia and at least one comorbidity</td><td align="left" rowspan="1" colspan="1">2.59</td><td align="left" rowspan="1" colspan="1">4.55</td></tr><tr><td align="left" rowspan="1" colspan="1">No insomnia and at least one comorbidity (<italic toggle="yes">n</italic>&#8197;=&#8197;80&#160;673)</td><td align="left" rowspan="1" colspan="1">$798</td><td align="left" rowspan="1" colspan="1">$140</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and at least one comorbidity (<italic toggle="yes">n</italic>&#8197;=&#8197;161&#160;414)</td><td align="left" rowspan="1" colspan="1">$2066</td><td align="left" rowspan="1" colspan="1">$637</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="T2Fn1"><p>SUD, substance use disorder. &#8220;At least one comorbidity&#8221; refers to at least one of depression, anxiety, and/or SUD.</p></fn></table-wrap-foot></table-wrap><p>To further explore these descriptive findings, generalized linear regression models were used to compare the total cost of care (TCC) for those with insomnia and their matched counterparts without insomnia. Using a natural logarithm link, the models naturally accounted for the skewed distribution of the costs and provided estimates that approximate percent differences in costs. Results of these models are displayed in <xref rid="T3" ref-type="table">Table 3</xref>. Consistently, those with insomnia had significantly higher costs (all <italic toggle="yes">p</italic>&#8197;&lt;&#8197;.001); members with insomnia, with no consideration of comorbid conditions, were estimated to have 74.1% (95% CI:[72.3%, 76.1%]) higher costs than those without insomnia. That is, regardless of the spending for a member without insomnia, a similar member with insomnia would be predicted to have 75% higher costs. All comorbid comparisons showed even higher estimated differences, ranging from 85% higher (substance use disorders) to over 108% higher costs (depression).</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3.</label><caption><p>Generalized Linear Regression Models Comparing Total Cost of Care for Members With and Without Insomnia in Each Matched Cohort</p></caption><table frame="hsides" rules="groups" width="100%" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Comparison</th><th align="left" rowspan="1" colspan="1">Estimate</th><th align="left" rowspan="1" colspan="1">95% CI</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>-value</th><th align="left" rowspan="1" colspan="1">Observations</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Insomnia vs. no insomnia</td><td align="left" rowspan="1" colspan="1">0.742</td><td align="left" rowspan="1" colspan="1">0.723, 0.761</td><td align="left" rowspan="1" colspan="1">&lt;.001</td><td align="left" rowspan="1" colspan="1">533&#160;422</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and depression vs. no insomnia and depression</td><td align="left" rowspan="1" colspan="1">1.086</td><td align="left" rowspan="1" colspan="1">1.058, 1.114</td><td align="left" rowspan="1" colspan="1">&lt;.001</td><td align="left" rowspan="1" colspan="1">195&#160;424</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and anxiety vs. no insomnia and anxiety</td><td align="left" rowspan="1" colspan="1">0.941</td><td align="left" rowspan="1" colspan="1">0.916, 0.966</td><td align="left" rowspan="1" colspan="1">&lt;.001</td><td align="left" rowspan="1" colspan="1">272&#160;723</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and SUD vs. no insomnia and SUD</td><td align="left" rowspan="1" colspan="1">0.853</td><td align="left" rowspan="1" colspan="1">0.800, 0.906</td><td align="left" rowspan="1" colspan="1">&lt;.001</td><td align="left" rowspan="1" colspan="1">54&#160;112</td></tr><tr><td align="left" rowspan="1" colspan="1">Insomnia and at least one comorbidity vs. no insomnia and at least one comorbidity</td><td align="left" rowspan="1" colspan="1">0.949</td><td align="left" rowspan="1" colspan="1">0.928, 0.971</td><td align="left" rowspan="1" colspan="1">&lt;.001</td><td align="left" rowspan="1" colspan="1">340&#160;410</td></tr></tbody></table><table-wrap-foot><fn id="T3Fn1"><p>All models were specified with a gamma distribution and natural logarithm link.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s10"><title>Discussion</title><p>Although widely under-recognized and under-treated, insomnia has among the greatest clinical, functional, and economic costs on patients, providers, and payors. To help shed light on the clinical and financial need and opportunity for addressing insomnia, the current study examined the current prevalence of insomnia and comorbid behavioral health conditions, as well as costs associated with members with such conditions.</p><p>The results with respect to prevalence reveal a high rate of insomnia, especially so among older members. Furthermore, it is noteworthy that close to two-thirds of those with insomnia also had a depression, anxiety, and/or substance use disorder diagnosis. These findings are consistent with previous research showing cooccurrence of insomnia with depression and anxiety in particular, a relationship that is likely bidirectional [<xref rid="CIT0051" ref-type="bibr">51</xref>], although the findings of the current analysis, which leverage claims data and extend beyond a treatment-seeking patient population, suggest that the cooccurrence may be even greater than previously recognized [<xref rid="CIT0052" ref-type="bibr">52</xref>, <xref rid="CIT0053" ref-type="bibr">53</xref>].</p><p>The results of the analyses examining health care costs associated with individuals with insomnia add to the early body of literature showing the significant financial impact of insomnia and suggest a large financial opportunity associated with addressing insomnia [<xref rid="CIT0030" ref-type="bibr">30</xref>, <xref rid="CIT0032" ref-type="bibr">32</xref>, <xref rid="CIT0054" ref-type="bibr">54</xref>, <xref rid="CIT0055" ref-type="bibr">55</xref>]. It is noteworthy that median total health care costs among individuals with insomnia were 4&#8211;6 times greater than among those without insomnia, and mean total costs were 2&#8211;3 times greater. Furthermore, 21% of total claim spend came from members with insomnia; while these costs cannot be attributed directly to insomnia, this amount exceeds what would be expected based on the proportional representation of insomnia (8.9%) in the total membership.</p><p>While direct comparison of the results from the financial impact analyses with those from prior studies is difficult due to differences in design, sample, and methods in studies of this type, there are some notable observations when comparing the current findings with past analyses. In some instances, expenditures associated with insomnia documented in the current evaluation are higher than those reported previously. For example, in their comparison of claims data for patients with and without insomnia, Ozminkowski and colleagues found that those with insomnia had mean TCC approximately 1.25 times higher than those without insomnia over a 6-month period, and this ratio was comparable for older (&#8805;65) and younger adults (18&#8211;64) [<xref rid="CIT0030" ref-type="bibr">30</xref>]. Furthermore, in comparisons of 12 months of claims data for patients with a depressive disorder with and without insomnia, Asche and colleagues found that older adults (&#8805;65) with cooccurring insomnia had mean TCC 1.17 times higher than those with a depressive disorder without insomnia, and younger adults (18&#8211;64) had total costs 1.21 times higher [<xref rid="CIT0054" ref-type="bibr">54</xref>]. Notably, the differences may be related in significant part to differences in how insomnia was operationalized and in the specific samples (e.g. mixed-age, older adults, etc.) across studies. For instance, relative to Ozminkowski and colleagues, the current study was more inclusive in terms of insomnia diagnoses and insomnia-related medications. Relative to Asche and colleagues, the current study was more inclusive in terms of medications to identify insomnia. Whereas Asche and colleagues excluded antidepressant medications that could be used to treat insomnia or depression, we specified dose requirements for these medications (e.g. trazodone, doxepin, and amitriptyline) consistent with their use in the treatment of insomnia, potentially optimizing sensitivity to detect insomnia as well as specificity to identify cases as insomnia versus depression. Furthermore, the current study was more specific and conservative in its identification of insomnia compared to Asche and colleagues, who included sleep disorders other than insomnia in their definition (e.g. hypersomnia unspecified).</p><p>Other studies have reported higher direct expenditures associated with insomnia, though included additional costs than those accounted for in the current analyses and used methods other than propensity matching. For example, Daley and colleagues, using self-report data from a large Canadian sample, included costs associated with alcohol used as a sleep aid [<xref rid="CIT0055" ref-type="bibr">55</xref>]. Wickwire and colleagues analyzed claims data for a sample of older Medicare beneficiaries to compare patients with and without insomnia but used statistical methods to control for covariates instead of propensity matching and included the cost of nursing home care [<xref rid="CIT0032" ref-type="bibr">32</xref>]. Notably, the findings from the current regression analyses demonstrating the TCC for those with insomnia to be estimated to be 74% higher than those without insomnia is in line with the results from smaller analyses of health plan members showing that those with moderate and severe insomnia had total health care costs that were, on average, 75% larger than those without insomnia [<xref rid="CIT0034" ref-type="bibr">34</xref>].</p><p>The high prevalence and considerable costs associated with insomnia point to the significant need and opportunity to promote the availability of gold-standard treatment for insomnia. In fact, the current findings served as a key basis for the development of a structured implementation initiative to establish new capability to deliver CBT-I within routine primary care and behavioral health settings of the Allegheny Health Network (see article reporting on patient and provider outcomes from this pilot implementation initiative in this issue) [<xref rid="CIT0047" ref-type="bibr">47</xref>].</p><p>While the current evaluation has a number of strengths, there are important limitations that should be considered. With respect to the analysis of health care costs of members with and without insomnia, it is important to highlight that while insomnia may contribute to increased health care costs, the current analysis is descriptive in nature and does not provide a causal link demonstrating that the increased cost is directly related to insomnia. However, a strength of the current analysis that supports these differences as likely due to insomnia was the use of matched comparisons of members with and without insomnia, which reduces the potential influence of other variables in the analysis of costs associated with insomnia.</p><p>Two additional limitations are worth noting. First, in the prevalence analyses, it was not possible to stratify prevalence by race/ethnicity, as this information is often not included in claims and therefore not reliably available. Second, in assuming a more conservative approach, consistent with other recent approaches [<xref rid="CIT0032" ref-type="bibr">32</xref>], we excluded some medications (e.g. low-dose quetiapine) that may be prescribed for sleep problems given that these medications may be used for other purposes (e.g. initiation of treatment for psychosis, augmentation for depression treatment). Accordingly, the current findings related to prevalence of insomnia may under-reflect the true rate of insomnia in the community.</p><p>In sum, the foregoing results related to the prevalence and financial impact of insomnia suggest that greater attention be paid to addressing insomnia and its common cooccurrence and relationship with other conditions. The findings reported herein suggest significant clinical and financial impact opportunity to payors for promoting identification of insomnia and increasing the availability of evidence-based treatment. Given the limited recognition, under-reporting, and under-detection of insomnia that is pervasive within primary care and specialty settings [<xref rid="CIT0038" ref-type="bibr">38</xref>, <xref rid="CIT0039" ref-type="bibr">39</xref>], the current study suggests the potential opportunity for payors and providers to leverage indicators (e.g. medications, diagnostic information) within claims and EHR data, such as those methods used within this study, to systematically identify possible insomnia and, when identified, proactively outreach to members and/or PCPs for further assessment and referral to treatment. Such a proactive identification and outreach approach offers considerable potential for greatly increasing and accelerating detection and for promoting engagement in effective treatment.</p></sec><sec id="s11" sec-type="supplementary-material"><title>Supplementary Material</title><p>Supplementary material is available at <italic toggle="yes">SLEEP Advances</italic> online.</p><supplementary-material id="sup1" position="float" content-type="local-data" orientation="portrait"><label>zpae054_suppl_Supplementary_Material</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zpae054_suppl_supplementary_material.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><sec id="s12"><title>Funding</title><p>This project was supported by the Richard King Mellon Foundation (Grant #10714) and Highmark Health.</p></sec><sec id="s13"><title>Author Contributions</title><p>Bradley Karlin (Conceptualization [lead], Formal analysis [supporting], Funding acquisition [lead], Investigation [lead], Methodology [equal], Project administration [equal], Writing&#8212;original draft [lead], Writing&#8212;review &amp; editing [lead]), Ryan Anderson (Conceptualization [supporting], Data curation [supporting], Formal analysis [supporting], Methodology [supporting], Project administration [equal], Writing&#8212;original draft [supporting], Writing&#8212;review &amp; editing [supporting]), Jillian Rung (Conceptualization [supporting], Data curation [equal], Formal analysis [supporting], Methodology [equal], Software [lead], Writing&#8212;original draft [supporting], Writing&#8212;review &amp; editing [supporting]), Charlotte Drury-Gworek (Data curation [supporting], Formal analysis [supporting], Methodology [supporting], Software [supporting], Writing&#8212;review &amp; editing [supporting]), and Tyson Barrett (Conceptualization [supporting], Data curation [equal], Formal analysis [lead], Methodology [equal], Writing&#8212;original draft [supporting], Writing&#8212;review &amp; editing [supporting]).</p></sec><ref-list id="r1"><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Morin</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Jarrin</surname><given-names>DC.</given-names></string-name></person-group><article-title>Epidemiology of insomnia: prevalence, course, risk factors, and public health burden</article-title>. <source>Sleep Med Clin</source>. <year>2022</year>;<volume>17</volume>(<issue>2</issue>):<fpage>173</fpage>&#8211;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jsmc.2022.03.003</pub-id><pub-id pub-id-type="pmid">35659072</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal"><collab>National Institutes of Health</collab>. <article-title>National institutes of health state of the science conference statement on manifestations and management of chronic insomnia in adults, june 13-15, 2005</article-title>. <source>Sleep.</source><year>2005</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1049</fpage>&#8211;<lpage>1057</lpage>. doi: <pub-id pub-id-type="doi">10.1093/sleep/28.9.1049</pub-id><pub-id pub-id-type="pmid">16268373</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bloom</surname><given-names>HG</given-names></string-name>, <string-name name-style="western"><surname>Ahmed</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Alessi</surname><given-names>CA</given-names></string-name></person-group>, <etal>et al</etal><article-title>Evidence-based recommendations for the assessment and management of sleep disorders in older persons</article-title>. <source>J Am Geriatr Soc.</source><year>2009</year>;<volume>57</volume>(<issue>5</issue>):<fpage>761</fpage>&#8211;<lpage>789</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2009.02220.x</pub-id><pub-id pub-id-type="pmid">19484833</pub-id><pub-id pub-id-type="pmcid">PMC2748127</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Neikrug</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Ancoli-Israel</surname><given-names>S.</given-names></string-name></person-group><article-title>Sleep disorders in the older adult - a mini-review</article-title>. <source>Gerontology</source>. <year>2010</year>;<volume>56</volume>(<issue>2</issue>):<fpage>181</fpage>&#8211;<lpage>189</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000236900</pub-id><pub-id pub-id-type="pmid">19738366</pub-id><pub-id pub-id-type="pmcid">PMC2842167</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Katz</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>McHorney</surname><given-names>CA.</given-names></string-name></person-group><article-title>The relationship between insomnia and health-related quality of life in patients with chronic illness</article-title>. <source>J Fam Pract.</source><year>2002</year>;<volume>51</volume>(<issue>3</issue>):<fpage>229</fpage>&#8211;<lpage>235</lpage>.<pub-id pub-id-type="pmid">11978233</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schwartz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McDowell Anderson</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Cornoni-Huntley</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hays</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Blazer</surname><given-names>D.</given-names></string-name></person-group><article-title>Insomnia and heart disease: a review of epidemiologic studies</article-title>. <source>J Psychosom Res.</source><year>1999</year>;<volume>47</volume>(<issue>4</issue>):<fpage>313</fpage>&#8211;<lpage>333</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0022-3999(99)00029-x</pub-id><pub-id pub-id-type="pmid">10616226</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Martin</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Fiorentino</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Jouldjian</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Josephson</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Alessi</surname><given-names>CA.</given-names></string-name></person-group><article-title>Sleep quality in residents of assisted living facilities: effect on quality of life, functional status, and depression</article-title>. <source>J Am Geriatr Soc.</source><year>2010</year>;<volume>58</volume>(<issue>5</issue>):<fpage>829</fpage>&#8211;<lpage>836</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2010.02815.x</pub-id><pub-id pub-id-type="pmid">20722819</pub-id><pub-id pub-id-type="pmcid">PMC3377484</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reid</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Martinovich</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Finkel</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Sleep: a marker of physical and mental health in the elderly</article-title>. <source>Am J Geriatr Psychiatry.</source><year>2006</year>;<volume>14</volume>(<issue>10</issue>):<fpage>860</fpage>&#8211;<lpage>866</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.JGP.0000206164.56404.ba</pub-id><pub-id pub-id-type="pmid">17001025</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schubert</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Cruickshanks</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Dalton</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname><given-names>BEK</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Nondahl</surname><given-names>DM.</given-names></string-name></person-group><article-title>Prevalence of sleep problems and quality of life in an older population</article-title>. <source>Sleep.</source><year>2002</year>;<volume>25</volume>(<issue>8</issue>):<fpage>889</fpage>&#8211;<lpage>893</lpage>.<pub-id pub-id-type="pmid">12489896</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dam</surname><given-names>TTL</given-names></string-name>, <string-name name-style="western"><surname>Ewing</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ancoli-Israel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ensrud</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Redline</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Stone</surname><given-names>K</given-names></string-name></person-group>; <collab>Osteoporotic Fractures in Men Research Group</collab>. <article-title>Association between sleep and physical function in older men: the osteoporotic fractures in men sleep study</article-title>. <source>J Am Geriatr Soc.</source><year>2008</year>;<volume>56</volume>(<issue>9</issue>):<fpage>1665</fpage>&#8211;<lpage>1673</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2008.01846.x</pub-id><pub-id pub-id-type="pmid">18759758</pub-id><pub-id pub-id-type="pmcid">PMC2631084</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Latimer Hill</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cumming</surname><given-names>RG</given-names></string-name>, <string-name name-style="western"><surname>Lewis</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Carrington</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Le Couteur</surname><given-names>DG.</given-names></string-name></person-group><article-title>Sleep disturbances and falls in older people</article-title>. <source>J Gerontol A Biol Sci Med Sci.</source><year>2007</year>;<volume>62</volume>(<issue>1</issue>):<fpage>62</fpage>&#8211;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/62.1.62</pub-id><pub-id pub-id-type="pmid">17301039</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stone</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Ancoli-Israel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Blackwell</surname><given-names>T</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Actigraphy-measured sleep characteristics and risk of falls in older women</article-title>. <source>Arch Intern Med.</source><year>2008</year>;<volume>168</volume>(<issue>16</issue>):<fpage>1768</fpage>&#8211;<lpage>1775</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinte.168.16.1768</pub-id><pub-id pub-id-type="pmid">18779464</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kaufmann</surname><given-names>CN</given-names></string-name>, <string-name name-style="western"><surname>Canham</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Mojtabai</surname><given-names>R</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Insomnia and health services utilization in middle-aged and older adults: results from the Health and Retirement Study</article-title>. <source>J Gerontol A Biol Sci Med Sci.</source><year>2013</year>;<volume>68</volume>(<issue>12</issue>):<fpage>1512</fpage>&#8211;<lpage>1517</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/glt050</pub-id><pub-id pub-id-type="pmid">23666943</pub-id><pub-id pub-id-type="pmcid">PMC3814231</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dew</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Hoch</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Buysse</surname><given-names>DJ</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Healthy older adults&#8217; sleep predicts all-cause mortality at 4 to 19 years of follow-up</article-title>. <source>Psychosom Med.</source><year>2003</year>;<volume>65</volume>(<issue>1</issue>):<fpage>63</fpage>&#8211;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.psy.0000039756.23250.7c</pub-id><pub-id pub-id-type="pmid">12554816</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Scott</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Webb</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Martyn-St James</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rowse</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Weich</surname><given-names>S.</given-names></string-name></person-group><article-title>Improving sleep quality leads to better mental health: a meta-analysis of randomised controlled trials</article-title>. <source>Sleep Med Rev.</source><year>2021</year>;<volume>60</volume>:<fpage>101556</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2021.101556</pub-id><pub-id pub-id-type="pmid">34607184</pub-id><pub-id pub-id-type="pmcid">PMC8651630</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cho</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Olmstead</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Levin</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Oxman</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Irwin</surname><given-names>MR.</given-names></string-name></person-group><article-title>Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults</article-title>. <source>Sleep.</source><year>2013</year>;<volume>36</volume>(<issue>11</issue>):<fpage>1685</fpage>&#8211;<lpage>1691</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.3128</pub-id><pub-id pub-id-type="pmid">24179302</pub-id><pub-id pub-id-type="pmcid">PMC3792386</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sofi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Cesari</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Casini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Macchi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Abbate</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Gensini</surname><given-names>GF.</given-names></string-name></person-group><article-title>Insomnia and risk of cardiovascular disease: a meta-analysis</article-title>. <source>Eur J Prev Cardiolog</source>. <year>2014</year>;<volume>21</volume>(<issue>1</issue>):<fpage>57</fpage>&#8211;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1177/2047487312460020</pub-id><pub-id pub-id-type="pmid">22942213</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Amer</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Hamza</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>El Akkad</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Abdel Galeel</surname><given-names>YII.</given-names></string-name></person-group><article-title>Does self-reported sleep quality predict poor cognitive performance among elderly living in elderly homes</article-title>? <source>Aging Ment Health.</source><year>2013</year>;<volume>17</volume>(<issue>7</issue>):<fpage>788</fpage>&#8211;<lpage>792</lpage>. doi: <pub-id pub-id-type="doi">10.1080/13607863.2013.790930</pub-id><pub-id pub-id-type="pmid">23621835</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blackwell</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yaffe</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ancoli-Israel</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal>.; <collab>Study of Osteoporotic Fractures Group</collab>. <article-title>Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures</article-title>. <source>J Gerontol A Biol Sci Med Sci.</source><year>2006</year>;<volume>61</volume>(<issue>4</issue>):<fpage>405</fpage>&#8211;<lpage>410</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/61.4.405</pub-id><pub-id pub-id-type="pmid">16611709</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cricco</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Simonsick</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Foley</surname><given-names>DJ.</given-names></string-name></person-group><article-title>The impact of insomnia on cognitive functioning in older adults</article-title>. <source>J Am Geriatr Soc.</source><year>2001</year>;<volume>49</volume>(<issue>9</issue>):<fpage>1185</fpage>&#8211;<lpage>1189</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1532-5415.2001.49235.x</pub-id><pub-id pub-id-type="pmid">11559377</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jelicic</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bosma</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ponds</surname><given-names>RWHM</given-names></string-name>, <string-name name-style="western"><surname>Van Boxtel</surname><given-names>MPJ</given-names></string-name>, <string-name name-style="western"><surname>Houx</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Jolles</surname><given-names>J.</given-names></string-name></person-group><article-title>Subjective sleep problems in later life as predictors of cognitive decline. Report from the Maastricht Ageing Study (MAAS)</article-title>. <source>Int J Geriatr Psychiatry.</source><year>2002</year>;<volume>17</volume>(<issue>1</issue>):<fpage>73</fpage>&#8211;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1002/gps.529</pub-id><pub-id pub-id-type="pmid">11802234</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lo</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Loh</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sim</surname><given-names>SKY</given-names></string-name>, <string-name name-style="western"><surname>Chee</surname><given-names>MWL.</given-names></string-name></person-group><article-title>Sleep duration and age-related changes in brain structure and cognitive performance</article-title>. <source>Sleep.</source><year>2014</year>;<volume>37</volume>(<issue>7</issue>):<fpage>1171</fpage>&#8211;<lpage>1178</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.3832</pub-id><pub-id pub-id-type="pmid">25061245</pub-id><pub-id pub-id-type="pmcid">PMC4098802</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Miyata</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Noda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Iwamoto</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kawano</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Okuda</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ozaki</surname><given-names>N.</given-names></string-name></person-group><article-title>Poor sleep quality impairs cognitive performance in older adults</article-title>. <source>J Sleep Res.</source><year>2013</year>;<volume>22</volume>(<issue>5</issue>):<fpage>535</fpage>&#8211;<lpage>541</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jsr.12054</pub-id><pub-id pub-id-type="pmid">23560612</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yaffe</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Falvey</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Hoang</surname><given-names>T.</given-names></string-name></person-group><article-title>Connections between sleep and cognition in older adults</article-title>. <source>Lancet Neurol.</source><year>2014</year>;<volume>13</volume>(<issue>10</issue>):<fpage>1017</fpage>&#8211;<lpage>1028</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(14)70172-3</pub-id><pub-id pub-id-type="pmid">25231524</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Elwood</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Bayer</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Fish</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pickering</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mitchell</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Gallacher</surname><given-names>JEJ.</given-names></string-name></person-group><article-title>Sleep disturbance and daytime sleepiness predict vascular dementia</article-title>. <source>J Epidemiol Community Health.</source><year>2011</year>;<volume>65</volume>(<issue>9</issue>):<fpage>820</fpage>&#8211;<lpage>824</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jech.2009.100503</pub-id><pub-id pub-id-type="pmid">20675705</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hahn</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>HX</given-names></string-name>, <string-name name-style="western"><surname>Andel</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Fratiglioni</surname><given-names>L.</given-names></string-name></person-group><article-title>A change in sleep pattern may predict Alzheimer disease</article-title>. <source>Am J Geriatr Psychiatry.</source><year>2014</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1262</fpage>&#8211;<lpage>1271</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jagp.2013.04.015</pub-id><pub-id pub-id-type="pmid">23954041</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Spira</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Gamaldo</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>An</surname><given-names>Y</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Self-reported sleep and &#946;-amyloid deposition in community-dwelling older adults</article-title>. <source>JAMA Neurol</source>. <year>2013</year>;<volume>70</volume>(<issue>12</issue>):<fpage>1537</fpage>&#8211;<lpage>1543</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.4258</pub-id><pub-id pub-id-type="pmid">24145859</pub-id><pub-id pub-id-type="pmcid">PMC3918480</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sivertsen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lallukka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Salo</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Pallesen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hysing</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Krokstad</surname><given-names>S.</given-names></string-name></person-group><article-title>Simon &#216;verland. Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT Study in Norway</article-title>. <source>J Sleep Res.</source><year>2014</year>;<volume>23</volume>(<issue>2</issue>):<fpage>124</fpage>&#8211;<lpage>132</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jsr.12102</pub-id><pub-id pub-id-type="pmid">24635564</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Natsky</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Vakulin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chai-Coetzer</surname><given-names>CL</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Economic evaluation of cognitive behavioural therapy for insomnia (CBT-I) for improving health outcomes in adult populations: a systematic review</article-title>. <source>Sleep Med Rev.</source><year>2020</year>;<volume>54</volume>:<fpage>101351</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2020.101351</pub-id><pub-id pub-id-type="pmid">32739824</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ozminkowski</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Walsh</surname><given-names>JK.</given-names></string-name></person-group><article-title>The direct and indirect costs of untreated insomnia in adults in the United States</article-title>. <source>Sleep.</source><year>2007</year>;<volume>30</volume>(<issue>3</issue>):<fpage>263</fpage>&#8211;<lpage>273</lpage>. doi: <pub-id pub-id-type="doi">10.1093/sleep/30.3.263</pub-id><pub-id pub-id-type="pmid">17425222</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Darden</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Espie</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Carl</surname><given-names>JR</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States</article-title>. <source>Sleep.</source><year>2021</year>;<volume>44</volume>(<issue>4</issue>). doi: <pub-id pub-id-type="doi">10.1093/sleep/zsaa223</pub-id><pub-id pub-id-type="pmid">33151330</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wickwire</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Tom</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Scharf</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Vadlamani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bulatao</surname><given-names>IG</given-names></string-name>, <string-name name-style="western"><surname>Albrecht</surname><given-names>JS.</given-names></string-name></person-group><article-title>Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries</article-title>. <source>Sleep.</source><year>2019</year>;<volume>42</volume>(<issue>4</issue>). doi: <pub-id pub-id-type="doi">10.1093/sleep/zsz007</pub-id><pub-id pub-id-type="pmcid">PMC6448286</pub-id><pub-id pub-id-type="pmid">30649500</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wickwire</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Juday</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Kelkar</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Heo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Margiotta</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Frech</surname><given-names>FH.</given-names></string-name></person-group><article-title>Economic burden of comorbid insomnia in 5 common medical disease subgroups</article-title>. <source>J Clin Sleep Med.</source><year>2023</year>;<volume>19</volume>(<issue>7</issue>):<fpage>1293</fpage>&#8211;<lpage>1302</lpage>. doi: <pub-id pub-id-type="doi">10.5664/jcsm.10592</pub-id><pub-id pub-id-type="pmid">37394794</pub-id><pub-id pub-id-type="pmcid">PMC10315590</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sarsour</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kalsekar</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Swindle</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Foley</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Walsh</surname><given-names>JK.</given-names></string-name></person-group><article-title>The association between insomnia severity and healthcare and productivity costs in a health plan sample</article-title>. <source>Sleep.</source><year>2011</year>;<volume>34</volume>(<issue>4</issue>):<fpage>443</fpage>&#8211;<lpage>450</lpage>. doi: <pub-id pub-id-type="doi">10.1093/sleep/34.4.443</pub-id><pub-id pub-id-type="pmid">21461322</pub-id><pub-id pub-id-type="pmcid">PMC3065254</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Amari</surname><given-names>DT</given-names></string-name>, <string-name name-style="western"><surname>Juday</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Frech</surname><given-names>FH</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines</article-title>. <source>BMC Geriatr.</source><year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>484</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-022-03165-6</pub-id><pub-id pub-id-type="pmid">35658904</pub-id><pub-id pub-id-type="pmcid">PMC9166444</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McCrae</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Bramoweth</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Roth</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mosti</surname><given-names>C.</given-names></string-name></person-group><article-title>Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs</article-title>. <source>J Clin Sleep Med.</source><year>2014</year>;<volume>10</volume>(<issue>2</issue>):<fpage>127</fpage>&#8211;<lpage>135</lpage>. doi: <pub-id pub-id-type="doi">10.5664/jcsm.3436</pub-id><pub-id pub-id-type="pmid">24532995</pub-id><pub-id pub-id-type="pmcid">PMC3899314</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thiart</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ebert</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Lehr</surname><given-names>D</given-names></string-name></person-group>, <etal>et al</etal>. <article-title>Internet-based cognitive behavioral therapy for insomnia: a health economic evaluation</article-title>. <source>Sleep.</source><year>2016</year>;<volume>39</volume>(<issue>10</issue>):<fpage>1769</fpage>&#8211;<lpage>1778</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.6152</pub-id><pub-id pub-id-type="pmid">27450686</pub-id><pub-id pub-id-type="pmcid">PMC5020359</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ogeil</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Chakraborty</surname><given-names>SP</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Lubman</surname><given-names>DI.</given-names></string-name></person-group><article-title>Clinician and patient barriers to the recognition of insomnia in family practice: a narrative summary of reported literature analysed using the theoretical domains framework</article-title>. <source>BMC Fam Pract.</source><year>2020</year>;<volume>21</volume>:<fpage>1</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12875-019-1070-0</pub-id><pub-id pub-id-type="pmid">31901226</pub-id><pub-id pub-id-type="pmcid">PMC6942394</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Grandner</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Chakravorty</surname><given-names>S.</given-names></string-name></person-group><article-title>Insomnia in primary care: misreported, mishandled, and just plain missed</article-title>. <source>J Clin Sleep Med</source>. <year>2017</year>;<volume>13</volume>(<issue>8</issue>):<fpage>937</fpage>&#8211;<lpage>939</lpage>. doi: <pub-id pub-id-type="doi">10.5664/jcsm.6688</pub-id><pub-id pub-id-type="pmid">28728626</pub-id><pub-id pub-id-type="pmcid">PMC5529129</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Grandner</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Oliveri</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ahuja</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Busser</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Freidank</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>McCall</surname><given-names>W.</given-names></string-name></person-group><article-title>The burden of untreated insomnia disorder in a sample of 1 million adults: a cohort study | BMC Public Health | Full Text</article-title>. <source>BMC Public Health</source>. <year>2023</year>;<volume>23</volume>(<issue>1481</issue>):<fpage>1</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-023-16329-9</pub-id><pub-id pub-id-type="pmid">37537544</pub-id><pub-id pub-id-type="pmcid">PMC10399052</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pagel</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Pandi-Perumal</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Monti</surname><given-names>JM.</given-names></string-name></person-group><article-title>Treating insomnia with medications | Sleep Science and Practice</article-title>. <source>Sleep Sci Pract</source>. <year>2018</year>;<volume>2</volume>(<issue>5</issue>):<fpage>1</fpage>&#8211;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s41606-018-0025-z</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van Straten</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>van der Zweerde</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kleiboer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cuijpers</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Morin</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Lancee</surname><given-names>J.</given-names></string-name></person-group><article-title>Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis</article-title>. <source>Sleep Med Rev.</source><year>2018</year>;<volume>38</volume>:<fpage>3</fpage>&#8211;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smrv.2017.02.001</pub-id><pub-id pub-id-type="pmid">28392168</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Simon</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Steinmetz</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Feige</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Benz</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Spiegelhalder</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Baumeister</surname><given-names>H.</given-names></string-name></person-group><article-title>Comparative efficacy of onsite, digital, and other settings for cognitive behavioral therapy for insomnia: a systematic review and network meta-analysis</article-title>. <source>Sci Rep.</source><year>2023</year>;<volume>13</volume>:<fpage>1</fpage>&#8211;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-023-28853-0</pub-id><pub-id pub-id-type="pmid">36732610</pub-id><pub-id pub-id-type="pmcid">PMC9894949</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Karlin</surname><given-names>BE</given-names></string-name>, <string-name name-style="western"><surname>Trockel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Spira</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Manber</surname><given-names>R.</given-names></string-name></person-group><article-title>National evaluation of the effectiveness of cognitive behavioral therapy for insomnia among older versus younger veterans</article-title>. <source>Int J Geriatr Psychiatry.</source><year>2015</year>;<volume>30</volume>(<issue>3</issue>):<fpage>308</fpage>&#8211;<lpage>315</lpage>. doi: <pub-id pub-id-type="doi">10.1002/gps.4143</pub-id><pub-id pub-id-type="pmid">24890708</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Trockel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Karlin</surname><given-names>BE</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Manber</surname><given-names>R.</given-names></string-name></person-group><article-title>Effects of cognitive behavioral therapy for insomnia on suicidal ideation in veterans</article-title>. <source>Sleep.</source><year>2015</year>;<volume>38</volume>(<issue>2</issue>):<fpage>259</fpage>&#8211;<lpage>265</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.4410</pub-id><pub-id pub-id-type="pmid">25515115</pub-id><pub-id pub-id-type="pmcid">PMC4288607</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koffel</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bramoweth</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Ulmer</surname><given-names>C.</given-names></string-name></person-group><article-title>Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review | Journal of General Internal Medicine</article-title>. <source>J Gen Intern Med.</source><year>2018</year>;<volume>33</volume>:<fpage>955</fpage>&#8211;<lpage>962</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11606-018-4390-1</pub-id><pub-id pub-id-type="pmid">29619651</pub-id><pub-id pub-id-type="pmcid">PMC5975165</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Karlin</surname><given-names>BE</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Rung</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Drury-Gworek</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Barrett</surname><given-names>TS.</given-names></string-name></person-group><article-title>Impact of real-world implementation of evidence-based insomnia treatment within a large payor-provider health system: Initial provider and patient-level outcomes</article-title>. <source>SLEEP&#160;Advances</source>. 2024:zpae053. doi: 10.1093/sleepadvances/zpae053</mixed-citation></ref><ref id="CIT0048"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sarsour</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sheridan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jutte</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Nuru-Jeter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hinshaw</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Boyce</surname><given-names>WT.</given-names></string-name></person-group><article-title>Family socioeconomic status and child executive functions: the roles of language, home environment, and single parenthood</article-title>. <source>J Int Neuropsychol Soc.</source><year>2011</year>;<volume>17</volume>(<issue>1</issue>):<fpage>120</fpage>&#8211;<lpage>132</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1355617710001335</pub-id><pub-id pub-id-type="pmid">21073770</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pollack</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Seal</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Joish</surname><given-names>VN</given-names></string-name>, <string-name name-style="western"><surname>Cziraky</surname><given-names>MJ.</given-names></string-name></person-group><article-title>Insomnia-related comorbidities and economic costs among a commercially insured population in the United States</article-title>. <source>Curr Med Res Opin.</source><year>2009</year>;<volume>25</volume>(<issue>8</issue>):<fpage>1901</fpage>&#8211;<lpage>1911</lpage>. doi: <pub-id pub-id-type="doi">10.1185/03007990903035505</pub-id><pub-id pub-id-type="pmid">19530979</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Charlson</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Pompei</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ales</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>MaeKenzie</surname><given-names>CR</given-names></string-name></person-group>. <article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>. <source>J Chronic Dis.</source><year>1987</year>;<volume>40</volume>(<issue>5</issue>):<fpage>373</fpage>&#8211;<lpage>383</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0021-9681(87)90171-8</pub-id><pub-id pub-id-type="pmid">3558716</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alvaro</surname><given-names>PK</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>JK.</given-names></string-name></person-group><article-title>A Systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression</article-title>. <source>Sleep.</source><year>2013</year>;<volume>36</volume>(<issue>7</issue>):<fpage>1059</fpage>&#8211;<lpage>1068</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.2810</pub-id><pub-id pub-id-type="pmid">23814343</pub-id><pub-id pub-id-type="pmcid">PMC3669059</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52.</label><mixed-citation publication-type="book"><collab>American Psychiatric Association, DSM-5 Task Force</collab>. <source>Diagnostic and Statistical Manual of Mental Disorders: DSM-5TM, 5th Ed</source>. <publisher-name>American Psychiatric Publishing, Inc</publisher-name>.; <year>2013</year>:<fpage>xliv</fpage>&#8211;<lpage>x947</lpage>. doi: <pub-id pub-id-type="doi">10.1176/appi.books.9780890425596</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blank</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lamers</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Hickie</surname><given-names>IB</given-names></string-name>, <string-name name-style="western"><surname>Merikangas</surname><given-names>KR.</given-names></string-name></person-group><article-title>Health correlates of insomnia symptoms and comorbid mental disorders in a nationally representative sample of US adolescents</article-title>. <source>Sleep.</source><year>2015</year>;<volume>38</volume>(<issue>2</issue>):<fpage>197</fpage>&#8211;<lpage>204</lpage>. doi: <pub-id pub-id-type="doi">10.5665/sleep.4396</pub-id><pub-id pub-id-type="pmid">25325502</pub-id><pub-id pub-id-type="pmcid">PMC4288600</pub-id></mixed-citation></ref><ref id="CIT0054"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Asche</surname><given-names>CV</given-names></string-name>, <string-name name-style="western"><surname>Joish</surname><given-names>VN</given-names></string-name>, <string-name name-style="western"><surname>Camacho</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Drake</surname><given-names>CL.</given-names></string-name></person-group><article-title>The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder</article-title>. <source>Curr Med Res Opin.</source><year>2010</year>;<volume>26</volume>(<issue>8</issue>):<fpage>1843</fpage>&#8211;<lpage>1853</lpage>. doi: <pub-id pub-id-type="doi">10.1185/03007995.2010.488037</pub-id><pub-id pub-id-type="pmid">20515321</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daley</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Morin</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>LeBlanc</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gr&#233;goire</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Savard</surname><given-names>J.</given-names></string-name></person-group><article-title>The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers</article-title>. <source>Sleep.</source><year>2009</year>;<volume>32</volume>(<issue>1</issue>):<fpage>55</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">19189779</pub-id><pub-id pub-id-type="pmcid">PMC2625324</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>